Friday, 16 October 2026European Markets

ALTRI SGPS And NORSKE SKOG Have A High Dividend Yield And Return On Equity In The Paper & Paper Products Industry.

Loading stream...

(VIANEWS) - ALTRI SGPS (ALTR.LS) is among this list of stock assets with the highest dividend rate and return on equity on the Paper & Paper Products industry.

Financial Asset Price Forward Dividend Yield Return on Equity
ALTRI SGPS (ALTR.LS) €5.42 4.64% 8.56%
NORSKE SKOG (NSKOG.OL) kr42.98 1.54% 5.54%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ALTRI SGPS (ALTR.LS)

4.64% Forward Dividend Yield and 8.56% Return On Equity

Altri, SGPS, S.A. produces and sells cellulosic fibers and energy in Portugal and internationally. The company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. It is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.

Earnings Per Share

As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.22.

PE Ratio

ALTRI SGPS has a trailing twelve months price to earnings ratio of 24.64. Meaning, the purchaser of the share is investing €24.64 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.56%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALTRI SGPS's stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 750.43M for the twelve trailing months.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 21, 2024, the estimated forward annual dividend rate is 0.25 and the estimated forward annual dividend yield is 4.64%.

Sales Growth

ALTRI SGPS's sales growth for the next quarter is 39.3%.

More news about ALTRI SGPS.

2. NORSKE SKOG (NSKOG.OL)

1.54% Forward Dividend Yield and 5.54% Return On Equity

Norske Skog ASA engages in the production and sale of publication and packaging paper products in Norway, rest of Europe, North America, Australasia, Asia, and Africa. It operates in Publication paper Europe, Publication paper Australasia, and Packaging paper segments. The company offers newsprint paper products comprising standard newsprint and other papers; magazine papers, including super calendared and lightweight coated papers; and recycled containerboards. Its products are primarily used in newspapers and magazines, periodicals, catalogues, brochures, advertising materials, inserts/flyers, supplements, free-sheets, directories, direct mail, and books. Norske Skog ASA was founded in 1962 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NORSKE SKOG has a trailing twelve months EPS of kr5.27.

PE Ratio

NORSKE SKOG has a trailing twelve months price to earnings ratio of 8.16. Meaning, the purchaser of the share is investing kr8.16 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.54%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORSKE SKOG's stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is a negative 140.6% and a negative 110.3%, respectively.

More news about NORSKE SKOG.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com